Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma
University of Washington
University of Washington
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Institute of Hematology & Blood Diseases Hospital, China
Dana-Farber Cancer Institute
Masonic Cancer Center, University of Minnesota
Sanofi
City of Hope Medical Center
Dana-Farber Cancer Institute
City of Hope Medical Center
City of Hope Medical Center
M.D. Anderson Cancer Center
University of Nebraska
University of Nebraska
University of Washington
St. Jude Children's Research Hospital
University of California, San Diego
Lund University Hospital
H. Lee Moffitt Cancer Center and Research Institute
Medical College of Wisconsin
University of Maryland, Baltimore
St. Jude Children's Research Hospital
Gruppo Italiano Malattie EMatologiche dell'Adulto
University of Washington
Montefiore Medical Center
Wake Forest University Health Sciences
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
Fred Hutchinson Cancer Center
St. Jude Children's Research Hospital
Barbara Ann Karmanos Cancer Institute
University of Washington
Alliance for Clinical Trials in Oncology
M.D. Anderson Cancer Center
SWOG Cancer Research Network
City of Hope Medical Center
Children's Oncology Group
National Cancer Institute (NCI)
Texas Oncology Cancer Center
Centre Henri Becquerel
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Case Comprehensive Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)